Cargando…
Ex Vivo Integration of Human Stem Retinal Ganglion Cells into the Mouse Retina
Cell replacement therapies may be key in achieving functional recovery in neurodegenerative optic neuropathies diseases such as glaucoma. One strategy that holds promise in this regard is the use of human embryonic stem cell and induced pluripotent stem-derived retinal ganglion cells (hRGCs). Previo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600680/ https://www.ncbi.nlm.nih.gov/pubmed/36291110 http://dx.doi.org/10.3390/cells11203241 |